Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Pilot Randomized Trial With Flecainide in ARVC Patients

ClinicalTrials.gov ID: NCT03685149

Public ClinicalTrials.gov record NCT03685149. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 1:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03685149
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Rochester
Other
Enrollment
22 participants

Conditions and interventions

Interventions

  • Flecainide Pill Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 22, 2019
Primary completion
Jul 30, 2022
Completion
Jul 30, 2022
Last update posted
Aug 19, 2024

2019 – 2022

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
University of Colorado Denver Colorado 80045
John Hopkins University Baltimore Maryland 21287
New York University New York New York 10016
University of Rochester Medical Center Rochester New York 14642
Duke University Durham North Carolina 27710
University of Pensylvania Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03685149, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03685149 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →